TIBO derivatives: a new class of potent and selective inhibitors of HIV-1 replication

Rudi Pauwels; K Andries; Zeger Debyser; Michael J. Kukla; Jan Desmyter; Paj Janssen; De Clercq Erik

Related publications

Article1992

TIBO derivatives: a new class of highly potent and specific inhibitors of HIV-1 replication

Rudi Pauwels, Koen Andries, Zeger Debyser, Michael J. Kukla, Dominique Schols, Jan Desmyter, De Clercq Erik, Paul A. J. Janssen

Article1990

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

Rudi Pauwels, Koen Andries, Jan Desmyter, Dominique Schols, Michael J. Kukla, Henry J. Breslin, Alfons Raeymaeckers, Jozef Van Gelder, Robert Woestenborghs, J. Heykants, K H Schellekens, M. Janssen, De Clercq Erik, Paul A. J. Janssen

Article1992

Highly potent and selective inhibition of HIV-1 replication by 6-phenylthiouracil derivatives

Masanori Baba, Shirô Shigeta, Hiromichi Tanaka, Tadashi Miyasaka, Masaru Ubasawa, Kohei Umezu, Richard Walker, Rudi Pauwels, De Clercq Erik

Article1992

Potent and highly selective HIV-1 specific inhibition by a new series of phenylacetamide derivatives targeted at HIV-1 RT

Rudi Pauwels, K Andries, Zeger Debyser, Peter Van Daele, Dominique Schols, M.G.J Janssen, Jan Desmyter, De Clercq Erik, Paj Janssen

Article1992

Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.

De Clercq Erik, Naoki Yamamoto, Rudi Pauwels, Masanori Baba, Dominique Schols, Hiroshi Nakashima, Jan Balzarini, Zeger Debyser, Barry A. Murrer, David H. Schwartz

TIBO derivatives: a new class of potent and selective inhibitors of HIV-1 replication

Discussion(0)

Related publications

TIBO derivatives: a new class of highly potent and specific inhibitors of HIV-1 replication

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

Highly potent and selective inhibition of HIV-1 replication by 6-phenylthiouracil derivatives

Potent and highly selective HIV-1 specific inhibition by a new series of phenylacetamide derivatives targeted at HIV-1 RT

Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.